Background: The maternal and infant microbiome may influence infant cardiovascular risk through immune programming. The maternal vagino-enteric microbiome is often sampled for group B streptococcus (GBS) colonization during pregnancy. Our aim was to investigate the association between maternal GBS colonization, intrapartum antibiotics, antenatal pet exposure and infant aortic intima-media thickness (aIMT), an intermediate vascular phenotype, and whether this association varied by mode of delivery. Methods: The Barwon Infant Study is a population-derived pre-birth cohort. Perinatal data were collected on participants. Women were tested for vagino-enteric group B streptococcus (GBS) colonization during third trimester. Six-week infant aIMT was measured by trans-abdominal ultrasound. Adjustment for confounders included maternal age, pre-pregnancy body mass index (BMI), smoking, socioeconomic status, gestational diabetes, length of gestation, infant sex, birthweight and aortic internal diameter. Results: Data were available on 835 mother-infant pairs. Of these, 574 (69%) women delivered vaginally; of those, 129 (22%) were GBS-colonized; and of these women, 111 (86%) received prophylactic intrapartum antibiotics. An association between maternal GBS colonization and infant aIMT was observed among those delivered vaginally (b ¼ 19.5 mm, 95% CI 9.5, 29.4; P < 0.0001) but not by Caesarean section (P for interaction ¼ 0.02). A similar pattern was seen for intrapartum antibiotics. There was a negative association between antenatal pet exposure and aIMT observed in those delivered vaginally.
Conclusion: Maternal GBS colonization and intrapartum antibiotics were associated with increased infant aIMT in those delivered vaginally, whereas antenatal pet exposure was associated with decreased aIMT. These data suggest that differences in early life microbial experience may contribute to an increased cardiovascular risk.
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Background
Atherosclerotic cardiovascular disease, a leading cause of morbidity and mortality, has its origins in early life. 1 Studies have implicated the ante-and perinatal periods as a developmental window that influences long-term cardiometabolic health. 1, 2 The underlying mechanisms are unclear, partly because there have been few in-depth studies of early life programming and cardiovascular risk markers. Perinatal microbial colonization of the infant represents a critical window in early life immune programming, that may have long-term cardiometabolic consequences. [3] [4] [5] The infant gastrointestinal tract is rapidly colonized after birth, leading to the establishment of the microbiome which plays an important role in the education and maturation of immune responses, 6 ,7 maintenance of gastrointestinal epithelial integrity 8 and metabolic signalling and energy harvesting. 5, 7, 8 Perturbation of the infant microbiome (dysbiosis) may lead to low-grade inflammation and increased metabolic risk, [3] [4] [5] but there is a relative paucity of longitudinal human data. Environmental factors associated with the establishment and diversity of the infant microbiome include the maternal microbiome, 9 pet and livestock exposure in the prenatal and early postnatal periods, family size, antibiotic use during pregnancy or delivery 10 and mode of delivery. 11 Initial bacterial colonization is determined by the maternal vagino-enteric microbiome in vaginal deliveries, and by the environmental and maternal skin microbiome in caesarean deliveries. 9 These pioneer bacteria strongly influence the infant's subsequent microbial signature. 10, 12, 13 The maternal vagino-enteric microbiome, a key determinant of the initial colonization of the vaginally delivered infant, [14] [15] [16] undergoes significant change throughout pregnancy; in particular there is a relative increase in the abundance of streptococcal species as gestation proceeds. 9, 17 In Australia, screening for maternal group B streptococcus (GBS) colonization occurs during the third trimester of pregnancy, as a recommended strategy to inform the prevention of GBS sepsis in the newborn. In Australia, approximately 25% of pregnant women are GBS-colonized. 18 It is routine practice for GBS-colonized women who have a vaginal delivery to receive intrapartum antibiotics to minimize transmission of GBS to their infant. 18 Antibiotics given in the perinatal and neonatal periods may permanently alter infant microbiota, in particular decreasing the abundance of Bifidobacteria and Bacteroides species; 19 animal models suggest these species may protect against later obesity.
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Maternal GBS colonization may therefore influence infant microbial colonization either through exposure to a specific maternal vagino-enteric microbiome, or alternatively through the effect of intrapartum antibiotics on maternal-infant microbial transfer. Measurement of aortic intima-media thickness (aIMT) has become established as an early marker of cardiovascular risk. 23 In the early stages of atherosclerosis, there is diffuse thickening of the intima-media layers of the vessel wall, and formation of 'fatty streaks' 24 that may be evident in the infant aorta from early infancy. 25 Aortic IMT is an ultrasonic measurement of this diffuse thickening and a widely used putative marker of early cardiovascular risk. 26, 27 In previous small exposure-specific studies, maternal and infant variables, such as maternal obesity, smoking and infant intrauterine growth restriction, are associated with increased aIMT. [28] [29] [30] [31] [32] [33] [34] [35] [36] Furthermore, there is evidence that carotid IMT is increased in early childhood following acute infection, 37 and by other inflammatory conditions of childhood such as inflammatory bowel disease and Kawasaki Disease. 38 Although the association be-promising marker that may reflect sub-acute inflammation associated with early atherosclerotic change. 23, 26 To date no study has investigated the association between perinatal exposures and aIMT in early life. The aim of this study was to characterize the association between environmental exposures affecting infant microbial colonization, particularly maternal GBS colonization, intrapartum antibiotics, pet and livestock exposure and mode of delivery with infant aIMT.
Methods
The Barwon Infant Study (BIS) is a population-derived prebirth cohort (n ¼ 1074) of mother-infant pairs in southeastern Australia. 39 Women were recruited at their first antenatal hospital visit and were subsequently excluded if their infants were delivered before 32 weeks, developed a serious illness in the first week of life or had major congenital abnormalities. The Barwon Health Human Research Ethics committee approved the study. Data on maternal age, parity, GBS colonization, antibiotic use in pregnancy, delivery type, intrapartum antibiotic use and antenatal comorbidities were collected from questionnaires and hospital databases. Questionnaires specific to pre-pregnancy, trimester 1 and trimester 2 were administered at recruitment. [28] [29] [30] [31] [32] Data relating to the third trimester and post-delivery were obtained by questionnaires selfcompleted before the 6-week visit. Maternal pre-pregnancy BMI was calculated from pre-pregnancy weight (self-report) and directly measured maternal height. Results of glucose tolerance testing were obtained from pathology databases, and gestational diabetes was defined on diagnosis and treatment using the consensus criteria applicable at the time of recruitment. 40, 41 In Australia, GBS screening is one of two recommended strategies to identify pregnant women whose infants are at risk from GBS sepsis, the other being risk stratification of the infant post-delivery. 42 Screening involves a combined low vaginal and ano-rectal swab at 35-37 weeks of gestation. 42 GBS screening was the strategy recommended by Barwon Health. Australian guidelines recommend all women undergoing caesarean section receive prophylactic antibiotics before first incision, 43 and that GBS-colonized women having a vaginal delivery should also receive antibiotics before delivery. 42 Questionnaire data provided information on variables that may affect the maternal and infant microbiome, including sibling numbers, pet ownership, livestock exposure and maternal smoking. Birth-related data were recorded within 48 h of delivery. The Socio-economic Index for Areas (SEIFA) was calculated using the home address of participants. 44 Aortic IMT was measured at a study centre visit at 6 weeks of age by trans-abdominal ultrasound. Images of the distal aorta were captured using a GE Vivid I with a 4-13 MHz linear array vascular transducer, as previously described. 45 The ultrasound settings were standardized by using presets and images acquired with simultaneous three-lead electrocardiogram (ECG) gating. The abdominal aorta was first identified in cross section, just above the umbilicus. A longitudinal, straight, unbranched 1-cm segment of abdominal aorta proximal to the abdominal bifurcation was captured between the umbilicus and xiphisternum, using a standard protocol. 27, 35, 45 Mean aIMT was measured offline using edge-detection software (Carotid Analyzer for Research, version 6, Medical Imaging Applications LLC, Iowa), by one of two readers. The between-reader intra-class coefficient was 0.92. 45 
Statistical analysis
Associations between antenatal and postnatal variables and aIMT were investigated using Pearson's correlation and linear regression analysis and categorical variables were investigated using logistic regression. The relationship between maternal GBS colonization and infant aIMT was investigated by linear regression modelling. Infant aIMT approximated a normal distribution. Models were investigated for the effect of outliers and extreme values and there was no substantive change in the findings. In addition to infant sex, potential confounding variables for associations with the outcome (aIMT) were chosen based on previous evidence that they affected maternal or infant microbiota or infant aIMT. They were then included in the model and retained if they made greater than a 10% difference to the magnitude of the effect estimate. As discussed in detail elsewhere, aIMT increases in proportion to vessel size in the growing infant; thus to investigate any further increase above this physiological phenomenon, minimal vessel diameter was controlled for in all regression analyses. 46 Interactions between exposure variables GBS colonization and mode of delivery were assessed by the significance of the Wald test associated with the relevant product term in multiple regression models. 47 GBS colonization and antibiotic use were highly correlated and therefore additional models were fitted including both exposure variables, in order to assess the independent association of each with aIMT.
In the cohort of 835, data regarding socioeconomic status (SEIFA), pet ownership, livestock exposure during pregnancy, maternal pre-pregnancy BMI, GBS colonization and minimal vessel diameter were infrequently missing for some individuals (Table 1) . Sensitivity analyses for the effect of these missing data (assuming missing at random) were performed using multiple imputation by chained equations (50 imputed datasets). Analysis of association with GBS colonization only included women for whom this exposure was recorded. All statistical analysis was performed using Stata 13.1 (Stata Corp, College Station, TX).
Results

Baseline characteristics of the cohort:
Of the 1158 women who were recruited, 53 withdrew and 41 were ineligible, leaving a total of 1074 women in the study and 39 984 infants attended the first postnatal visit at a median age of 5.9 weeks, [interquartile range (IQR) 5.14-6.86]. Of these, 835 (85%) had aIMT successfully measured. 45 The characteristics of these 835 participants are summarized in Table 1 . There was minimal difference in characteristics between the 835 participants and the rest of the cohort (Supplementary Table 5 , available as Supplementary data at IJE online).
Maternal GBS colonization
Of the 835 women, 757 (91%) were screened for GBS colonization; 156 of those screened (21%) were colonized. Of the women who did not have screening (n ¼ 78), 20 had infants born at <37 weeks of gestation and 43 (55%) had caesarean deliveries. There was no obvious difference in the other maternal characteristics when compared with women who underwent GBS screening. Among women who delivered vaginally, only 35 of 574 (6%) did not have GBS screening.
Maternal antibiotic use in pregnancy
In all, 130 women (16%) had a total of 205 antibiotic courses prescribed during pregnancy, of which 71 courses (35%) were either amoxicillin or penicillin, and 35 (17%) were cephalexin. Broad-spectrum antibiotics, such as coamoxyclav and ceftriaxone, were prescribed in fewer than 5% of courses. The prevalence of maternal GBS colonization was lower among those prescribed antibiotics in pregnancy (143/640, 22% vs 13/117, 11%, P ¼ 0.006). The magnitude of this difference was greatest for women prescribed antibiotics in the second and third trimester (trimester 1: 5/31, 16% vs 151/726, 21%; trimester 2: 6/65, 9% vs 150/692, 22%; trimester 3: 3/32, 9% vs 153/725, 21%).
Intrapartum antibiotics
Intrapartum antibiotics were administered due to either caesarean section or maternal GBS colonization. All women who delivered by caesarean section received intrapartum antibiotics, predominantly as surgical prophylaxis.
Of women who delivered vaginally, 128/574 (22%) received antibiotics, including 111/129 (86%) who were GBS-colonized and 5/410 (1%) who were GBS-negative (35 women had unknown GBS colonization).
Associations between antenatal factors, GBS colonization and intrapartum antibiotics
Other than antibiotic use in pregnancy, there was no evidence that other antenatal or maternal variables, including maternal age, parity, socioeconomic status or pet exposure, were asscociated with GBS colonization (Table 2) . The odds of intrapartum antibiotics increased with Caesarean delivery, GBS colonization, higher pre-pregnancy BMI, prematurity and reduced birthweight.
Maternal GBS colonization and infant aIMT
There was a strong positive association between maternal GBS colonization and mean aIMT (mean increase ¼ 14.1 mm, 95%, CI 5.6, 23.0, P ¼ 0.002). When stratified by mode of delivery, the association between maternal GBS and offspring aIMT was observed in infants born by vaginal delivery (b ¼ 19.5 mm, 95% CI 9.5, 29.4, P < 0.001) but not in those born by caesarean section (b ¼ À6.6, 95% CI À26.5, 13.3, P ¼ 0.51; P for interaction ¼ 0.02) ( Table 3 ).
In infants born by vaginal delivery, the association between maternal GBS colonization and infant mean aIMT persisted after adjustment for socioeconomic status, pet ownership, livestock ownership, maternal age, prepregnancy BMI, antibiotic exposure in pregnancy, length of gestation, sex, birthweight, age at aIMT measurement and minimal vessel diameter (b ¼ 22.6 mm, 95% CI 11.9, 33.3, P < 0.001). Sensitivity analysis using multiple imputation for missing data produced largely similar results for the association between GBS colonization and aIMT (overall b ¼ 13.5 mm, 95% CI 4.9, 22.1, P ¼ 0.002; vaginal delivery b ¼ 18.6 mm, 95% CI 8.9, 28.3, P < 0.001).
Infants were then classified considering both GBS status and mode of delivery, with those born by caesarean section (Table 4) .
Association between intrapartum antibiotics and infant aIMT
In women who had a caesarean delivery, there were no infants unexposed to intrapartum antibiotics. In vaginal deliveries, however, there was an association between intrapartum antibiotics and infant aIMT (b ¼ 11.3 mm, 95% CI 1.3, 21.4, P ¼ 0.03).
Maternal GBS colonization, intrapartum antibiotics and infant aIMT in vaginal deliveries
In vaginal deliveries, maternal GBS colonization and intrapartum antibiotics were highly correlated: 111/129 (86%) GBS-colonized women received intrapartum antibiotics, whereas only 5/410 (1%) GBS-negative women received antibiotics. In a regression model for aIMT that includes both GBS colonization and intrapartum antibiotics, the (adjusted) effect of GBS colonization remained substantial (b ¼ 20.5 mm, 95% CI À0.1, 41.3, P ¼ 0.05), whereas the effect of intrapartum antibiotics was strongly null (b ¼ À1.3 mm, 95% CI À22.8, 20.3, P ¼ 0.91). Because of the small number of GBS-negative and antibiotic-positive women, the adjusted GBS effect here is determined primarily within the subgroup of women who did not receive antibiotics (18/423 of whom were GBS-positive), whereas the adjusted effect of intrapartum antibiotics is driven mainly by the sub-group of GBS-positive women (111/129 of whom received antibiotics).
Other antenatal microbial exposures and infant aIMT
In this cohort, 620 of 835 women (74%) had a household pet and 59 (7%) had exposure to livestock. Excluding missing data regarding the type of pet owned, 69% of women owned dogs (473 of 688). There was an association between exposure to livestock (b ¼ À18.5 mm, 95% CI À34.3 to À2.6, P ¼ 0.02) and pet ownership (b ¼ À9.1 mm, 95% CI À18.6 to 0.43, P ¼ 0.06) and reduced aIMT in infants born via vaginal deliveries, whereas there was a positive association between livestock exposure and infant aIMT following caesarean delivery (Table 3) . Specifically, there was a negative association between dog ownership in pregnancy and infant aIMT, (b ¼ À11.5 mm, 95% CI À21.5 to À1.6, P ¼ 0.02), but not following caesarean delivery (b ¼ 1.7 mm, 95% CI À12.2 to 15.5, P ¼ 0.82). There was no association between sibling number and aIMT before or after stratification by mode of delivery.
Discussion
This study is the first to investigate the association between antenatal and perinatal factors that may affect the maternal-infant microbiome and aIMT at 6 weeks of age. Here we observe both markers of maternal microbial exposure and microbial transfer are associated with infant aIMT in vaginal, but not caesarean section, deliveries. This difference by mode of delivery also highlights effects on maternal-infant microbial transfer. In vaginal deliveries there was a positive association between maternal GBS colonization and increased infant aIMT, independent of birthweight and gestational age. Similarly, intrapartum antibiotics were associated with increased aIMT, whereas both pet ownership and livestock exposure were associated with reduced aIMT. Together these findings suggest that the very early microbial experience among vaginally born infants may have implications for cardiovascular health. Adjusted for socioeconomic status, pet ownership, livestock ownership, maternal age, pre-pregnancy BMI, antibiotic exposure in pregnancy, length of gestation, gender, birthweight, age at aIMT measurement and minimal vessel diameter. Infants born by vaginal delivery are known to be colonized with microbiota that resemble maternal vaginal and enteric flora, whereas those born by caesarean section have microbiota that resemble maternal skin flora. 48 It is therefore plausible that the association between GBS colonization and infant aIMT is mediated by infant exposure to maternal vaginal and enteric microbiota during delivery. Maternal GBS colonization may indicate an altered maternal microbiome that then colonizes the infant in vaginallyborn infants. Recent evidence suggests that maternal GBS colonization in pregnancy is associated with enrichment of the infant gastrointestinal microbiota with specific bacterial families (Clostridiaceae, Ruminococcoceae and Enterococcaceae) that is independent of maternal intrapartum antibiotic exposure. 49 In Australia, GBS screening is performed frequently, but not universally, by sampling both vaginal and enteric flora in late pregnancy. 42 Asymptomatic maternal GBS colonization occurs in 18-27% of Australian women, 18 compared with a varying global incidence of 6.5-36%. [50] [51] [52] Risk factors that predict GBS colonization remain poorly defined. 18 Inconsistently reported risk factors include younger maternal age and parity, 18, 53 reduced socioeconomic status, 51, 54 and, in contrast, increased maternal professional employment. 55 In our study, antibiotic use during pregnancy was the only antenatal exposure associated with GBS colonization. Antibiotic administration is known to alter the intestinal microbiome markedly. The most significant effect is within days of administration, but it may be months before the microbiome returns to its pre-treatment state. [56] [57] [58] In keeping with this, women in our cohort who received antibiotics during their second and third trimester had a lower incidence of GBS colonization than those receiving antibiotics in the first trimester. Previous studies have suggested an association between prenatal and early life antibiotic exposure and childhood obesity. 5, 59, 60 To date there are few data on the association between prenatal antibiotics and other cardiovascular risk factors. Here, there was no association between prenatal antibiotics and infant aIMT, either overall or after stratification by delivery. Consistent with the relevance of the maternal and maternal-infant microbial transfer, antenatal pet ownership and livestock exposure were associated with reduced aIMT, but only among infants delivered vaginally. Dog ownership is a key determinant of human microbiota, 61 including maternal vaginal colonization during pregnancy. 62 Pet ownership has been shown to both protect against offspring allergy 63, 64 and modify the association between caesarean delivery and offspring obesity. 65 It is considered likely that these findings are mediated by microbial factors. Here, we have shown that pet ownership has a similarly potentially protective effect on aIMT. Further characterization of maternal and infant microbiota would elucidate the relationship between maternal GBS colonization, intrapartum antibiotics and animal exposures, and microbial composition and metabolic profile. The finding of a positive association between livestock exposure and aIMT in those delivering by caesarean section is unexpected and requires replication in cohorts with a higher frequency of livestock exposure. Infant colonization is influenced not only by the maternal microbiome, but also by the mode of microbial transfer from mother to newborn. 48 For GBS-colonized women having vaginal deliveries, the role of intrapartum antibiotics is to reduce maternal-infant microbial transfer. 66 Due to the high correlation of maternal GBS colonization and intrapartum antibiotics in vaginal deliveries, we are unable to confidently differentiate between the two exposures in this study. However, the magnitude of association between maternal GBS and aIMT was essentially unchanged following adjustment for intrapartum antibiotics, whereas the association between intrapartum antibiotics and aIMT was no longer evident following adjustment for maternal GBS status. Further characterization of the maternal microbiome and the effect of GBS colonization would help clarify this relationship. Infant aIMT measurement allows the timely investigation of relationships between perinatal exposures and cardiovascular disease risk. Increased aIMT is a putative marker of cardiovascular disease risk, but there are no longitudinal data linking neonatal aIMT and cardiovascular disease in adulthood. 23 Carotid IMT has been shown to closely correlate with histological findings, 67 and is widely used in adults to predict cardiovascular events. 68, 69 In children, both carotid and aIMT have been associated with established risk factors for cardiovascular disease, with evidence that aIMT is a more discriminating measure. 70 As the aorta is the first site of atherosclerotic change, 25 aIMT has become an established early life marker of cardiovascular disease risk. 23 It is not yet known whether differences in infant aIMT persist through childhood. The magnitude of the observed changes in aIMT is similar to largely unadjusted data comparing other putative perinatal cardiovascular risk factors, such as gestational age, 32 smoking, gestational diabetes 29 and pre-eclampsia, 30 but somewhat less than that demonstrated with small exposure-specific studies of newborn intrauterine growth restriction (IUGR). 34, 35 Previous studies have demonstrated increased IMT following hospitalization with childhood infection. 37 In addition, severe childhood infection has been associated with subclinical atherosclerosis, 71 and with cardiovascular events in adulthood. 72 Our finding of an association between maternal GBS colonization and neonatal aIMT may be indicative of either a transitory inflammatory effect and/or early changes of atherosclerosis; further longitudinal studies are under way. The strengths of this study include a populationderived sample, the largest study of infant aIMT to date, multiple measures of microbial exposure, a high rate of GBS screening and a rate of GBS colonization in keeping with previous Australian data. 18 Aortic IMT was successfully measured in 85% of infants in our cohort, with no differences identified in participants where measurement was unsuccessful. 45 The main limitations of our study are that we so far only have a single measure of aIMT, and that we have not yet characterized the maternal and infant microbiota beyond GBS colonization. Intrapartum antibiotic administration was infrequent in non-GBS colonized women who had a vaginal delivery. This limited our ability to investigate the independent effect of specific antibiotic classes on GBS colonization or the effect of antibiotics on maternal infant microbial transfer in vaginal delivery. Maternal GBS colonization and intrapartum antibiotic administration are common, therefore any association with infant cardiovascular health may have significant public health implications. There is evidence that intrapartum antibiotics reduce early onset GBS disease in the neonate, 66 but the long-term implications for the infant microbiome are unknown. Given the importance of preventing neonatal GBS sepsis, it is likely that interventions aimed at supporting the infant microbiome are more appropriate than withholding intrapartum antibiotics.
Conclusion
Maternal GBS colonization is associated with increased infant aIMT, modified by mode of delivery. This is consistent with neonatal colonization with maternal vaginal and enteric microbiota during vaginal delivery, but not caesarean section. Furthermore, in these same infants, pet ownership and livestock exposure are associated with reduced aIMT. Together, these data raise the possibility that differences in early life microbial experience are involved in establishment of early cardiovascular risk. Further studies to quantify differences in microbiota associated with GBS colonization are warranted. Given the prevalence of both GBS colonization and cardiovascular disease, any association may have wide-reaching public health implications.
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